论文部分内容阅读
目的:观察吸入布地奈德治疗成人肺炎支原体肺炎的疗效及安全性.方法:治疗组38例,给予常规治疗(左氧氟沙星0.4g/d),同时给予布地奈德1m g+生理盐水2m l,b i d,雾化吸入,治疗时间10天.对照组给予常规治疗(左氧氟沙星0.4g/d),观察退热时间、咳嗽减轻时间、啰音消失时间.同时比较第一天及第五天治疗组及对照组血CRP、血沉、中性粒细胞比例变化.2周后复查胸部C T,比较病灶变化.结果:治疗组退热时间、咳嗽减轻时间、啰音消失时间均短于对照组,治疗组总有效率100%,对照组92.1%,差异有统计学意义.结论:雾化吸收布地奈德治疗肺炎支原体肺炎疗效显著,症状改善时间及有效率明显高于对照组.“,”Objective To observe the efficacy and safety of inhaled budesonide in the treatment of Adult Mycoplasma pneumoniae pneumonia.Methods Treatment group has 38 cases, Conventional treatment (Levofloxacin 0.4g/d), and atomization inhalation Budesonide 1mg+ Physiological saline 2ml ,bid,treatment duration was ten days. Control group received conventional treatment (Levofloxacin 0.4g/d), to observe the time of fever drops, cough relief, and the rales reduce. Compare the first day and the five day on CRP, ESR, and Neutrophil ratio between the treatment group and the control group. After 2 weeks, the changes of CT were compared.Results The treatment group was shorter than the control group on the time of temperature drops, cough relief, and rales reduce. The total effective rate of the treatment group was 92.1%,while the control group was 100%, the difference has statistically significant.Conclusion It is Obviously effective in treatment of Mycoplasma pneumoniaby inhaled Budesonide. The symptom improvement time and the effective rate were significantly higher than those in the control group.